# GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial

Study · id `cardio:ct-nct05693545` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05693545](<https://clinicaltrials.gov/study/NCT05693545>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05693545

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1004 participants.

## Technical summary

Registry record NCT05693545. Randomized; single masking; primary purpose treatment. Start 2023-09-01 (actual); primary completion 2026-10-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 1004 participants (enrolled count; ClinicalTrials.gov record NCT05693545, source copy `cardio:ctgov-nct05693545-2026-11-09`, retrieved 2026-11-18)
- Started: 2023-09-01 (actual) (ClinicalTrials.gov record NCT05693545, source copy `cardio:ctgov-nct05693545-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2026-10-31 (actual) (ClinicalTrials.gov record NCT05693545, source copy `cardio:ctgov-nct05693545-2026-11-09`, retrieved 2026-11-18)
- Completion: 2026-10-31 (actual) (ClinicalTrials.gov record NCT05693545, source copy `cardio:ctgov-nct05693545-2026-11-09`, retrieved 2026-11-18)
- Countries: Uganda (ClinicalTrials.gov record NCT05693545, source copy `cardio:ctgov-nct05693545-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05693545-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial
- Condition: Rheumatic Heart Disease
- Intervention (Drug): phenoxymethyl penicillin
- Intervention (Drug): intramuscular benzathine penicillin G (BPG) prophylaxis
- Lead sponsor: Children's Hospital Medical Center, Cincinnati
- Lead sponsor class: OTHER
- Collaborator: Uganda Heart Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Rheumatic heart disease (`cardio:rheumatic-heart-disease`)
- Registry lists this organization as the lead sponsor: Children's Hospital Medical Center, Cincinnati (`cardio:org-children-s-hospital-medical-center-cincinnati`)
- Registry lists this organization as a collaborator: Uganda Heart Institute (`cardio:org-uganda-heart-institute`)

## Provenance

Content hash: b4cc6c728d17ee37d7dad350a2fa84bbd63cb39bb3fd32ce01307c7394d8cd4e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
